Tetrandrine Induces Mitochondria-Mediated Apoptosis in Human Gastric Cancer BGC-823 Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Qin, Rong ^a   Shen, Huiling ^a   Cao, Yuan ^a   Fang, Yue ^a   Li, Hao ^a   Chen, Qiaoyun ^a   Xu, Wenlin ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA ACTIN; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; TETRANDRINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BAX GENE; BCL 2 GENE; BCLXL GENE; BETA ACTIN GENE; BINDING ASSAY; CANCER CELL CULTURE; CANCER INHIBITION; CELL CULTURE; CELL LINE BGC 823; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE COMPARISON; ENZYME ACTIVATION; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA ISOLATION; STEPHANIA TETRANDRA; STOMACH CANCER; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZYLISOQUINOLINES; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84885027804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076486     Document Type: Article

References (40)

1. Yang L, (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: 17-20. PubMed: 16440411.
2. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, et al. (2008) Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9: 279-287. doi:10.1016/S1470-2045(08)70072-X. PubMed: 18308253.
3. Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A, (2004) Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol 211: 287-295. PubMed: 17238139.
4. Lochhead P, El-Omar EM, (2008) Gastric cancer. Br Med Bull 85: 87-100. doi:10.1093/bmb/ldn007. PubMed: 18267927.
5. Meyer HJ, Wilke H, (2011) Treatment strategies in gastric cancer. Deut Arzteblatt Int 108: 698-706. PubMed: 22114638.
6. Zhang L, Ji Q, Ni ZH, Sun J, (2012) Prohibitin Induces Apoptosis in BGC823 Gastric Cancer Cells through the Mitochondrial Pathway. Asian Pac J Cancer Prev 13: 3803-3807. doi:10.7314/APJCP.2012.13.8.3803. PubMed: 23098474.
7. Pang L, Hoult JR, (1997) Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid, accompanied by an overproduction of prostaglandins. Biochem Pharmacol 53: 773-782. doi:10.1016/S0006-2952(96)00817-9. PubMed: 9113098.
8. Chen B, Sun Q, Wang X, Gao F, Dai Y, et al. (2008) Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells. Int J Nanomed 3: 277-286. PubMed: 18686787.
9. Cho HS, Chang SH, Chung YS, Gao F, Dai Y, et al. (2009) Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. J Vet Sci 10: 23-28. doi:10.4142/jvs.2009.10.1.23. PubMed: 19255520.
10. Li X, Su B, Liu R, Wu D, He D, (2011) Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J Surg Res 166: e45-e51. doi:10.1016/j.jss.2010.10.034. PubMed: 21176918.
11. Wu JM, Chen Y, Chen JC, Lin TY, Tseng SH, (2010) Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Cancer Lett 287: 187-195. doi:10.1016/j.canlet.2009.06.009. PubMed: 19586712.
12. Ng LT, Chiang LC, Lin YT, Lin CC, (2006) Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Am J Chin Med 34: 125-135. doi:10.1142/S0192415X06003692. PubMed: 16437745.
13. Jang BC, Lim KJ, Paik JH, Cho JW, Baek WK, et al. (2004) Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-delta in U937 cells. Biochem Pharmacol 67: 1819-1829. doi:10.1016/j.bcp.2004.01.018. PubMed: 15130759.
14. Li X, Lu X, Xu H, Zhu Z, Yin H, et al. (2012) Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on "oxidation therapy". Mol Pharm 9: 222-229. doi:10.1021/mp2002736. PubMed: 22171565.
15. Dorr RT, (1994) Pharmacology and toxicology of Cremophor EL diluents. Ann Pharmacother 28: S11-S14. PubMed: 7915152.
16. Bissery MC, Nohynek G, Sanderink GJ, Lavelle F, (1995) Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience. Anti Cancer Drugs 6: 339-368.
17. Tabuchi Y, Matsuoka J, Gunduz M, Imada T, Ono R, et al. (2009) Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. Int J Oncol 34: 313-319. PubMed: 19148464.
18. Wei J, Liu B, Wang L, Qian X, Ding Y, et al. (2007) Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines. Cancer Chemother Pharmacol 60: 703-711. doi:10.1007/s00280-007-0416-9. PubMed: 17256130.
19. Wei N, Liu GT, Chen XG, Liu Q, Wang FP, et al. (2011) H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2. Biochem Pharmacol 82: 1593-1603. doi:10.1016/j.bcp.2011.08.012. PubMed: 21864508.
20. Wang C, Youle RJ, (2009) The role of mitochondria in apoptosis. Annu Rev Genet 43: 95-118. doi:10.1146/annurev-genet-102108-134850. PubMed: 19659442.
21. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X, (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490. doi:10.1016/S0092-8674(00)81589-5. PubMed: 9727491.
22. Atsumi T, Kato K, Uno K, Iijima K, Koike T, et al. (2007) Pathophysiological role of the activation of p38 mitogen-activated protein kinases in poorly differentiated gastric cancer. Pathol Int 57: 635-644. doi:10.1111/j.1440-1827.2007.02152.x. PubMed: 17803652.
23. Parkin DM, Bray FI, Devesa SS, (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37: S4-S66. doi:10.1016/S0959-8049(01)80044-7. PubMed: 11602373.
24. Parkin DM, (2004) International variation. Oncogene 23: 6329-6340. doi:10.1038/sj.onc.1207726. PubMed: 15322508.
25. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917. doi:10.1002/ijc.25516. PubMed: 21351269.
26. Ford AC, (2011). Best practice & research. Clinical gastroenterology 25: 581-592. doi:10.1016/j.bpg.2011.09.002. PubMed: 22122773.
27. Roukos DH, Kappas AM, (2005). Nat Clin Practice Oncol 2: 98-107. doi:10.1038/ncponc0099.
28. Jiang M, Wang CY, Huang S, Yang T, Dong Z, (2009) Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway. Am J Physiol Renal Physiol 296: F983-F993. doi:10.1152/ajprenal.90579.2008. PubMed: 19279129.
29. Wu Y, Shen D, Chen Z, Clayton S, Vadgama JV, (2007) Taxol induced apoptosis regulates amino acid transport in breast cancer cells. Apoptosis 12: 593-612. doi:10.1007/s10495-006-0007-y. PubMed: 17195090.
30. Gu WJ, Liu HL, (2013) Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. Anti Cancer Drugs 24(6):: 566-76. PubMed: 23525071.
31. Pan X, Zhang X, Sun H, Zhang J, Yan M, et al. (2013) Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells. PLOS ONE 8: e56679. doi:10.1371/journal.pone.0056679. PubMed: 23441212.
32. Rogalska A, Marczak A, Gajek A, Szwed M, Śliwińska A, et al. (2013) Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B. Toxicol In Vitro 27: 239-49.
33. Fulda S, Debatin KM, (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-4811. doi:10.1038/sj.onc.1209608. PubMed: 16892092.
34. Hirsch T, Marzo I, Kroemer G, (1997) Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep 17: 67-76. doi:10.1023/A:1027339418683. PubMed: 9171922.
35. Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, et al. (2000) Two distinct pathways leading to nuclear apoptosis. J Exp Med 192: 571-580. doi:10.1084/jem.192.4.571. PubMed: 10952727.
36. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, et al. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2,-3,-6,-7,-8, and-10 in a caspase-9-dependent manner. J Cell Biol 144: 281-292. doi:10.1083/jcb.144.2.281. PubMed: 9922454.
37. Lee HJ, Lee HJ, Lee EO, Ko SG, Bae HS, et al. (2008) Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis. Cancer Lett 270: 342-353. doi:10.1016/j.canlet.2008.05.040. PubMed: 18617322.
38. Dai CL, Xiong HY, Tang LF, Zhang X, Liang YJ, et al. (2007) Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice. Cancer Chemother Pharmacol 60: 741-750. doi:10.1007/s00280-007-0420-0. PubMed: 17273824.
39. Zhu XM, Sui MH, Fan WM, (2005) In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel. Anticancer Res 25: 1953-1962. PubMed: 16158930.
40. Chen Y, Chen JC, Tseng SH, (2009) Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int J Cancer 124: 2260-2269. doi:10.1002/ijc.24208. PubMed: 19165864.